Aug 25, 2026 08:31AM
Aug 12, 2026 05:13PM
Aug 11, 2026 08:32AM
Aug 6, 2026 08:31AM
May 28, 2026 08:31AM
May 26, 2026 08:32AM
May 14, 2026 05:21PM RenovoRx, Inc. (RNXT) Misses Q1 EPS by 1c
Mar 26, 2026 08:30AM
Jan 30, 2026 01:01AM
Nov 14, 2025 04:40PM
Nov 13, 2025 05:52PM
Sep 25, 2025 08:31AM
Aug 14, 2025 05:03PM
Aug 6, 2025 08:30AM RenovoRx expands commercial reach for RenovoCath device to 13 centers
Jul 28, 2025 08:31AM
Jun 5, 2025 05:02AM
May 15, 2025 05:54PM
Apr 29, 2025 08:35AM
Apr 16, 2025 08:36AM
Apr 4, 2025 06:43AM
Apr 1, 2025 08:30AM RenovoRx (RNXT) Reports Initial Revenues from RenovoCath Commercialization, Provides Update on Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial
Mar 26, 2025 08:01AM
Feb 6, 2025 04:05PM
Dec 5, 2024 08:01AM
Sep 25, 2024 08:32AM
Jul 31, 2024 08:33AM
Jun 17, 2024 03:25AM
Jun 10, 2024 08:33AM RenovoRx (RNXT) Appoints Ryan Witt as SVP of Head of Corporate Strategy and Partnerships

456,369 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All